Top Markets
#1 EXOD EXOD +56.80%
#2 Cysic Cysic +14.17%
#3 Biconomy Biconomy +9.35%
#4 Fabric Protocol Fabric Protocol +7.20%
#5 Fake World Assets Fake World Assets +5.60%
#6 Collect on Fanable Collect on Fanable +4.30%
#7 Cap Cap +3.90%
#8 Dual Dual +3.58%
#9 Figure Heloc Figure Heloc +3.49%
#10 Avantis Avantis +3.32%
Coin of the day
EXOD EXOD
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Roquefort Therapeutics plc Roquefort Therapeutics plc

Roquefort Therapeutics plc

ROQ
Rang in Aktien #37956
Roquefort Therapeutics plc functions as a biotechnology firm, focusing its... Roquefort Therapeutics plc functions as a biotechnology firm, focusing its efforts on the discovery and development of innovative pharmaceutical treatments. The company's primary research objective is to develop therapies that target Midkine, a circulating growth factor protein and pro-inflammatory mediator, for applications in cancer treatment. Established in 2020, Roquefort Therapeutics plc has its main operations based in London, United Kingdom.
Aktienkurs
$0.10205262
Zuletzt synchronisiert: 2026-04-23
Marktkapitalisierung
$1.32M
Veränderung (1 Tag)
5.19%
Veränderung (1 Jahr)
-54.38%
Land
GB
Handel Roquefort Therapeutics plc (ROQ)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Roquefort Therapeutics plc (ROQ)
Dividendenrendite (TTM) von Roquefort Therapeutics plc (Aktienkürzel: ROQ) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Roquefort Therapeutics plc (ROQ) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.65%
BE